Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth Beevers

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
American Journal of Hypertension|January 9, 2003
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor managementDirk C Felmeden, Charles G C Spencer, Funmi M Belgore, et al.
The American Journal of Cardiology|August 14, 2003
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])Dirk C Felmeden, Charles G C Spencer, Natali A Y Chung, et al.
European Heart Journal|December 6, 2006
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes TrialPeter Sever, Björn Dahlöf, Neil Poulter, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Drugs|March 16, 2005
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
Lancet (London, England)|September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Peter S Sever, Neil R Poulter, et al.
European Heart Journal|January 8, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closurePeter S Sever, Neil R Poulter, Bjorn Dahlof, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Hypertension|January 9, 2003
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor managementDirk C Felmeden, Charles G C Spencer, Funmi M Belgore, et al.
The American Journal of Cardiology|August 14, 2003
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])Dirk C Felmeden, Charles G C Spencer, Natali A Y Chung, et al.
European Heart Journal|December 6, 2006
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes TrialPeter Sever, Björn Dahlöf, Neil Poulter, et al.
Lancet (London, England)|April 11, 2003
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Drugs|March 16, 2005
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter S Sever, Björn Dahlöf, Neil R Poulter, et al.
Diabetes Care|April 28, 2005
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)Peter S Sever, Neil R Poulter, Björn Dahlöf, et al.
Journal of Hypertension|October 16, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetesJan Ostergren, Neil R Poulter, Peter S Sever, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
Lancet (London, England)|September 13, 2005
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Peter S Sever, Neil R Poulter, et al.
European Heart Journal|January 8, 2008
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closurePeter S Sever, Neil R Poulter, Bjorn Dahlof, et al.
Pageof 8